DRUG GUIDELINE

Hydralazine (intravenous Severe Hypertension In Pregnancy)
SCOPE (Area): Maternity Unit, Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), (Exclude: Coronary Care Unit)
SCOPE (Staff): Medical, Nursing, Midwifery, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice) and General Wards


Preamble

See Appendix 1 for full version of this Drug Guideline.


Related Documents

CPP0119 - Hypertension Disorders In Pregnancy - Pre-Eclampsia/Eclampsia
CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved December 22, 2019 from
IBM Corporation. (2019). IBM Micromedex. Retrieved December 22, 2019, from
MIMS Online. (2019, December). MIMS Online, Apresoline product information. Retrieved December 22, 2019, from
Monash Health (2019, September). Hypertensive disorders in pregnancy, pre-eclampsia, eclampsia Clinical Guideline. Personal communication received Feb 10, 2020.
Queensland Government (2015, August) Queensland Clinical Guideline – Hypertensive disorders of pregnancy. Accessed on December 22, 2019 from
Rossi, S. (2019, July). Australian Medicines Handbook. Retrieved December 22, 2019, from
SOMANZ (2014, updated June 2015). Guidelines for the Management of Hypertensive Disorders of Pregnancy. Retrieved December 22, 2019 from
The Royal Women’s Hospital, Pharmacy Department. (2019). Pregnancy and Breastfeeding Medicines Guide. Retrieved December 22, 2019 from
The Society of Hospital Pharmacists of Australia. 2019, August. Australian Injectable Drugs Handbook (7th ed.). Retrieved December 22, 2019, from
The Women’s (2018, November). Hypertension - Management of acute. Retrieved December 22, 2019 from
The Women’s (2018, November). Pre-Eclampsia: Management. Retrieved December 22, 2019 from
Therapeutic Guidelines Limited. (2019, December). Therapeutic Guidelines. Retrieved December 22, 2019, from
Walters Kluwer. (2019) UpToDate, Drug Interaction section. Retrieved December 22, 2019, from,


Appendix

Appendix 1 -Hydralazine (intravenous – Severe Hypertension In Pregnancy)



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 30/09/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/06/2025
Hydralazine (intravenous Severe Hypertension In Pregnancy) - DRG0034 - Version: 6 - (Generated On: 26-04-2025 05:46)